Related Experiment Video
Updated: Jun 6, 2026
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Cognitive intervention for persons with mild cognitive impairment: A meta-analysis.
Huijie Li1, Juan Li, Nanxin Li
1Center on Aging Psychology, Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China. lihj@psych.ac.cn
Ageing Research Reviews
|December 7, 2010
Summary
Cognitive training shows significant benefits for individuals with mild cognitive impairment (MCI). This meta-analysis confirms improvements in overall cognition and self-ratings, suggesting it
Area of Science:
- Neuroscience
- Gerontology
- Cognitive Psychology
Background:
- Mild cognitive impairment (MCI) is a growing concern, with ongoing debate about the efficacy of cognitive interventions.
- Previous research on cognitive training for MCI has yielded mixed results, necessitating further investigation.
Purpose of the Study:
- To systematically evaluate the effectiveness of cognitive intervention in individuals diagnosed with mild cognitive impairment (MCI).
- To synthesize findings from multiple clinical studies to provide a comprehensive understanding of cognitive training benefits for MCI patients.
Main Methods:
- A meta-analysis was conducted, integrating data from seventeen diverse clinical studies focused on cognitive intervention for MCI.
- Statistical synthesis of quantitative and qualitative outcomes across studies was performed to assess overall and domain-specific effects.
Main Results:
- Cognitive training led to statistically significant improvements in both overall cognitive function and self-rated assessments in individuals with MCI.
- Moderate benefits were observed in language, self-rated anxiety, and functional abilities, while mild benefits were noted in episodic memory, executive functioning, and quality of life.
- Improvements were sustained in follow-up data, indicating lasting effects of the cognitive interventions.
Conclusions:
- Cognitive intervention represents a promising and effective strategy for enhancing cognitive and functional capacities in individuals with mild cognitive impairment (MCI).
- While benefits are evident, the degree of improvement can vary across different cognitive domains, highlighting the need for tailored interventions.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:17Cognitivism
Cognitive psychology emerged as a significant field in the mid-20th century. It focused on understanding humans' internal mental processes. This approach emphasizes how people perceive, remember, think, and solve problems—elements critical to human cognition.
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process information is...
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process information is...
01:26Metacognition
Metacognition is a conscious process where individuals are aware of their cognitive and executive processes, such as planning before solving a problem or self-monitoring during reading. For instance, a writer may need help with composing a piece. The situation involves a writer who is working on a piece of writing, but while doing so, they realize that something is missing. They notice that their characters lack depth or details. This realization occurs because the writer is reflecting on their...